Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

A mother's iron levels early in pregnancy can influence the DNA makeup of her child, potentially affecting the child's health.

Low testosterone levels may lead to more severe COVID-19 outcomes.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

AGA linked to worse COVID-19 outcomes in men.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Dutasteride and finasteride affect different cell types differently.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Possible link between COVID-19 and hair loss; more research needed.

The ACE1 gene variant doesn't affect long-COVID symptoms.